Immutep Limited
Get $10 bonus on your first $100 deposit for PRRUF
Get $10 bonus on your first $100 deposit for PRRUF
Immutep Limited (PRRUF) Stock Competitors & Peer Comparison
See (PRRUF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PRRUF | $0.07 | +8.33% | 95.8M | -0.93 | -$0.07 | N/A |
| NONOF | $38.42 | -5.33% | 176.5B | 11.07 | $3.59 | +4.63% |
| CSLLY | $24.79 | +0.49% | 96B | 16.10 | $1.54 | +2.95% |
| UCBJF | $305.59 | +1.32% | 61.4B | 34.29 | $9.41 | +0.49% |
| UCBJY | $154.93 | +1.89% | 58.6B | 32.76 | $4.70 | +0.51% |
| ARGNF | $894.76 | +25.66% | 55.4B | 45.70 | $19.58 | N/A |
| CMXHF | $97.43 | -2.88% | 47.3B | 15.79 | $6.17 | +3.00% |
| WXXWY | $9.39 | -1.16% | 19.3B | 27.42 | $0.34 | N/A |
| IVBXF | $11.11 | -0.77% | 19.1B | 158.73 | $0.07 | N/A |
| WXIBF | $4.60 | +0.00% | 19B | 27.06 | $0.17 | N/A |
Stock Comparison
PRRUF vs NONOF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, NONOF has a market cap of 176.5B. Regarding current trading prices, PRRUF is priced at $0.07, while NONOF trades at $38.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas NONOF's P/E ratio is 11.07. In terms of profitability, PRRUF's ROE is -0.53%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, PRRUF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check NONOF's competition here
PRRUF vs CSLLY Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, CSLLY has a market cap of 96B. Regarding current trading prices, PRRUF is priced at $0.07, while CSLLY trades at $24.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas CSLLY's P/E ratio is 16.10. In terms of profitability, PRRUF's ROE is -0.53%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, PRRUF is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check CSLLY's competition here
PRRUF vs UCBJF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, UCBJF has a market cap of 61.4B. Regarding current trading prices, PRRUF is priced at $0.07, while UCBJF trades at $305.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas UCBJF's P/E ratio is 34.29. In terms of profitability, PRRUF's ROE is -0.53%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, PRRUF is less volatile compared to UCBJF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check UCBJF's competition here
PRRUF vs UCBJY Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, UCBJY has a market cap of 58.6B. Regarding current trading prices, PRRUF is priced at $0.07, while UCBJY trades at $154.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas UCBJY's P/E ratio is 32.76. In terms of profitability, PRRUF's ROE is -0.53%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, PRRUF is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check UCBJY's competition here
PRRUF vs ARGNF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, ARGNF has a market cap of 55.4B. Regarding current trading prices, PRRUF is priced at $0.07, while ARGNF trades at $894.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas ARGNF's P/E ratio is 45.70. In terms of profitability, PRRUF's ROE is -0.53%, compared to ARGNF's ROE of +0.34%. Regarding short-term risk, PRRUF and ARGNF have similar daily volatility (0.00).Check ARGNF's competition here
PRRUF vs CMXHF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, CMXHF has a market cap of 47.3B. Regarding current trading prices, PRRUF is priced at $0.07, while CMXHF trades at $97.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas CMXHF's P/E ratio is 15.79. In terms of profitability, PRRUF's ROE is -0.53%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, PRRUF is less volatile compared to CMXHF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check CMXHF's competition here
PRRUF vs WXXWY Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, WXXWY has a market cap of 19.3B. Regarding current trading prices, PRRUF is priced at $0.07, while WXXWY trades at $9.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas WXXWY's P/E ratio is 27.42. In terms of profitability, PRRUF's ROE is -0.53%, compared to WXXWY's ROE of +0.11%. Regarding short-term risk, PRRUF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check WXXWY's competition here
PRRUF vs IVBXF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, IVBXF has a market cap of 19.1B. Regarding current trading prices, PRRUF is priced at $0.07, while IVBXF trades at $11.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas IVBXF's P/E ratio is 158.73. In terms of profitability, PRRUF's ROE is -0.53%, compared to IVBXF's ROE of +0.05%. Regarding short-term risk, PRRUF and IVBXF have similar daily volatility (0.00).Check IVBXF's competition here
PRRUF vs WXIBF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, WXIBF has a market cap of 19B. Regarding current trading prices, PRRUF is priced at $0.07, while WXIBF trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas WXIBF's P/E ratio is 27.06. In terms of profitability, PRRUF's ROE is -0.53%, compared to WXIBF's ROE of +0.11%. Regarding short-term risk, PRRUF is less volatile compared to WXIBF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check WXIBF's competition here
PRRUF vs GNMSF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, GNMSF has a market cap of 17.4B. Regarding current trading prices, PRRUF is priced at $0.07, while GNMSF trades at $281.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas GNMSF's P/E ratio is 18.34. In terms of profitability, PRRUF's ROE is -0.53%, compared to GNMSF's ROE of +0.19%. Regarding short-term risk, PRRUF and GNMSF have similar daily volatility (0.00).Check GNMSF's competition here
PRRUF vs SBHMY Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, SBHMY has a market cap of 14.2B. Regarding current trading prices, PRRUF is priced at $0.07, while SBHMY trades at $15.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas SBHMY's P/E ratio is 41.82. In terms of profitability, PRRUF's ROE is -0.53%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, PRRUF is less volatile compared to SBHMY. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check SBHMY's competition here
PRRUF vs SBMFF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, SBMFF has a market cap of 13.6B. Regarding current trading prices, PRRUF is priced at $0.07, while SBMFF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas SBMFF's P/E ratio is 25.33. In terms of profitability, PRRUF's ROE is -0.53%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, PRRUF and SBMFF have similar daily volatility (0.00).Check SBMFF's competition here
PRRUF vs BRRGF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, PRRUF is priced at $0.07, while BRRGF trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, PRRUF's ROE is -0.53%, compared to BRRGF's ROE of -0.97%. Regarding short-term risk, PRRUF is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check BRRGF's competition here
PRRUF vs AAVXF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, AAVXF has a market cap of 9.2B. Regarding current trading prices, PRRUF is priced at $0.07, while AAVXF trades at $115.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas AAVXF's P/E ratio is -22.11. In terms of profitability, PRRUF's ROE is -0.53%, compared to AAVXF's ROE of -1.65%. Regarding short-term risk, PRRUF and AAVXF have similar daily volatility (0.00).Check AAVXF's competition here
PRRUF vs ODTC Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, PRRUF is priced at $0.07, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas ODTC's P/E ratio is 1.07. In terms of profitability, PRRUF's ROE is -0.53%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, PRRUF and ODTC have similar daily volatility (0.00).Check ODTC's competition here
PRRUF vs TRSBF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, TRSBF has a market cap of 7.1B. Regarding current trading prices, PRRUF is priced at $0.07, while TRSBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas TRSBF's P/E ratio is 21.43. In terms of profitability, PRRUF's ROE is -0.53%, compared to TRSBF's ROE of +0.38%. Regarding short-term risk, PRRUF and TRSBF have similar daily volatility (0.00).Check TRSBF's competition here
PRRUF vs AKBLF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, AKBLF has a market cap of 6.3B. Regarding current trading prices, PRRUF is priced at $0.07, while AKBLF trades at $31.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas AKBLF's P/E ratio is 37.32. In terms of profitability, PRRUF's ROE is -0.53%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, PRRUF and AKBLF have similar daily volatility (0.00).Check AKBLF's competition here
PRRUF vs REGMF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, REGMF has a market cap of 6.2B. Regarding current trading prices, PRRUF is priced at $0.07, while REGMF trades at $10.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas REGMF's P/E ratio is 57.63. In terms of profitability, PRRUF's ROE is -0.53%, compared to REGMF's ROE of +0.27%. Regarding short-term risk, PRRUF is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check REGMF's competition here
PRRUF vs ABCZF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, PRRUF is priced at $0.07, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, PRRUF's ROE is -0.53%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, PRRUF and ABCZF have similar daily volatility (0.00).Check ABCZF's competition here
PRRUF vs LABFF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, PRRUF is priced at $0.07, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas LABFF's P/E ratio is 28.95. In terms of profitability, PRRUF's ROE is -0.53%, compared to LABFF's ROE of +0.23%. Regarding short-term risk, PRRUF and LABFF have similar daily volatility (0.00).Check LABFF's competition here
PRRUF vs SHJBF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, SHJBF has a market cap of 4.3B. Regarding current trading prices, PRRUF is priced at $0.07, while SHJBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas SHJBF's P/E ratio is -25.00. In terms of profitability, PRRUF's ROE is -0.53%, compared to SHJBF's ROE of -0.14%. Regarding short-term risk, PRRUF is less volatile compared to SHJBF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check SHJBF's competition here
PRRUF vs ZLDPF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, ZLDPF has a market cap of 3.6B. Regarding current trading prices, PRRUF is priced at $0.07, while ZLDPF trades at $51.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas ZLDPF's P/E ratio is 3.64. In terms of profitability, PRRUF's ROE is -0.53%, compared to ZLDPF's ROE of +0.48%. Regarding short-term risk, PRRUF is less volatile compared to ZLDPF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check ZLDPF's competition here
PRRUF vs TLPPF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, TLPPF has a market cap of 3.6B. Regarding current trading prices, PRRUF is priced at $0.07, while TLPPF trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas TLPPF's P/E ratio is -525.00. In terms of profitability, PRRUF's ROE is -0.53%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, PRRUF and TLPPF have similar daily volatility (0.00).Check TLPPF's competition here
PRRUF vs CAMRF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, CAMRF has a market cap of 3.3B. Regarding current trading prices, PRRUF is priced at $0.07, while CAMRF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas CAMRF's P/E ratio is 41.04. In terms of profitability, PRRUF's ROE is -0.53%, compared to CAMRF's ROE of +0.19%. Regarding short-term risk, PRRUF and CAMRF have similar daily volatility (0.00).Check CAMRF's competition here
PRRUF vs ASPHF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, ASPHF has a market cap of 3.2B. Regarding current trading prices, PRRUF is priced at $0.07, while ASPHF trades at $8.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas ASPHF's P/E ratio is -16.00. In terms of profitability, PRRUF's ROE is -0.53%, compared to ASPHF's ROE of -0.73%. Regarding short-term risk, PRRUF and ASPHF have similar daily volatility (0.00).Check ASPHF's competition here
PRRUF vs GNNSF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, GNNSF has a market cap of 3.1B. Regarding current trading prices, PRRUF is priced at $0.07, while GNNSF trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas GNNSF's P/E ratio is -5.68. In terms of profitability, PRRUF's ROE is -0.53%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, PRRUF is less volatile compared to GNNSF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check GNNSF's competition here
PRRUF vs BRCTF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, BRCTF has a market cap of 2.9B. Regarding current trading prices, PRRUF is priced at $0.07, while BRCTF trades at $33.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas BRCTF's P/E ratio is 26.85. In terms of profitability, PRRUF's ROE is -0.53%, compared to BRCTF's ROE of +0.52%. Regarding short-term risk, PRRUF is less volatile compared to BRCTF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check BRCTF's competition here
PRRUF vs MPSYF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, PRRUF is priced at $0.07, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, PRRUF's ROE is -0.53%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, PRRUF is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check MPSYF's competition here
PRRUF vs VGLS Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, VGLS has a market cap of 2.6B. Regarding current trading prices, PRRUF is priced at $0.07, while VGLS trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas VGLS's P/E ratio is N/A. In terms of profitability, PRRUF's ROE is -0.53%, compared to VGLS's ROE of +0.00%. Regarding short-term risk, PRRUF is less volatile compared to VGLS. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check VGLS's competition here
PRRUF vs BVNRY Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, BVNRY has a market cap of 2.5B. Regarding current trading prices, PRRUF is priced at $0.07, while BVNRY trades at $10.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas BVNRY's P/E ratio is 11.36. In terms of profitability, PRRUF's ROE is -0.53%, compared to BVNRY's ROE of +0.11%. Regarding short-term risk, PRRUF is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check BVNRY's competition here
PRRUF vs BVNKF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, BVNKF has a market cap of 2.4B. Regarding current trading prices, PRRUF is priced at $0.07, while BVNKF trades at $30.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas BVNKF's P/E ratio is 11.17. In terms of profitability, PRRUF's ROE is -0.53%, compared to BVNKF's ROE of +0.11%. Regarding short-term risk, PRRUF is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check BVNKF's competition here
PRRUF vs INCPF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, INCPF has a market cap of 2.3B. Regarding current trading prices, PRRUF is priced at $0.07, while INCPF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas INCPF's P/E ratio is 25.83. In terms of profitability, PRRUF's ROE is -0.53%, compared to INCPF's ROE of +0.09%. Regarding short-term risk, PRRUF is less volatile compared to INCPF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check INCPF's competition here
PRRUF vs ASCLF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, ASCLF has a market cap of 2.2B. Regarding current trading prices, PRRUF is priced at $0.07, while ASCLF trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas ASCLF's P/E ratio is -42.00. In terms of profitability, PRRUF's ROE is -0.53%, compared to ASCLF's ROE of -0.19%. Regarding short-term risk, PRRUF is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check ASCLF's competition here
PRRUF vs GENSF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, GENSF has a market cap of 2.2B. Regarding current trading prices, PRRUF is priced at $0.07, while GENSF trades at $33.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas GENSF's P/E ratio is 34.90. In terms of profitability, PRRUF's ROE is -0.53%, compared to GENSF's ROE of +0.10%. Regarding short-term risk, PRRUF is less volatile compared to GENSF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check GENSF's competition here
PRRUF vs GLPGF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, GLPGF has a market cap of 2.2B. Regarding current trading prices, PRRUF is priced at $0.07, while GLPGF trades at $33.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas GLPGF's P/E ratio is -4.15. In terms of profitability, PRRUF's ROE is -0.53%, compared to GLPGF's ROE of +0.11%. Regarding short-term risk, PRRUF and GLPGF have similar daily volatility (0.00).Check GLPGF's competition here
PRRUF vs MEOBF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, MEOBF has a market cap of 2.1B. Regarding current trading prices, PRRUF is priced at $0.07, while MEOBF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas MEOBF's P/E ratio is -22.86. In terms of profitability, PRRUF's ROE is -0.53%, compared to MEOBF's ROE of -0.14%. Regarding short-term risk, PRRUF and MEOBF have similar daily volatility (0.00).Check MEOBF's competition here
PRRUF vs PHMMF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, PHMMF has a market cap of 1.8B. Regarding current trading prices, PRRUF is priced at $0.07, while PHMMF trades at $106.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas PHMMF's P/E ratio is 46.29. In terms of profitability, PRRUF's ROE is -0.53%, compared to PHMMF's ROE of +0.35%. Regarding short-term risk, PRRUF and PHMMF have similar daily volatility (0.00).Check PHMMF's competition here
PRRUF vs ONTTF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, ONTTF has a market cap of 1.6B. Regarding current trading prices, PRRUF is priced at $0.07, while ONTTF trades at $1.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas ONTTF's P/E ratio is -8.30. In terms of profitability, PRRUF's ROE is -0.53%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, PRRUF is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check ONTTF's competition here
PRRUF vs BIESF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, PRRUF is priced at $0.07, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas BIESF's P/E ratio is -44.44. In terms of profitability, PRRUF's ROE is -0.53%, compared to BIESF's ROE of -0.05%. Regarding short-term risk, PRRUF and BIESF have similar daily volatility (0.00).Check BIESF's competition here
PRRUF vs CSPHF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, CSPHF has a market cap of 1.5B. Regarding current trading prices, PRRUF is priced at $0.07, while CSPHF trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas CSPHF's P/E ratio is -20.20. In terms of profitability, PRRUF's ROE is -0.53%, compared to CSPHF's ROE of -0.64%. Regarding short-term risk, PRRUF is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check CSPHF's competition here
PRRUF vs HBMHF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, HBMHF has a market cap of 1.3B. Regarding current trading prices, PRRUF is priced at $0.07, while HBMHF trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas HBMHF's P/E ratio is 17.33. In terms of profitability, PRRUF's ROE is -0.53%, compared to HBMHF's ROE of +0.36%. Regarding short-term risk, PRRUF is less volatile compared to HBMHF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check HBMHF's competition here
PRRUF vs SNBIF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, PRRUF is priced at $0.07, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, PRRUF's ROE is -0.53%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, PRRUF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check SNBIF's competition here
PRRUF vs PHGUF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, PHGUF has a market cap of 1.2B. Regarding current trading prices, PRRUF is priced at $0.07, while PHGUF trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas PHGUF's P/E ratio is -175.00. In terms of profitability, PRRUF's ROE is -0.53%, compared to PHGUF's ROE of +0.01%. Regarding short-term risk, PRRUF is less volatile compared to PHGUF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check PHGUF's competition here
PRRUF vs MDCLF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, PRRUF is priced at $0.07, while MDCLF trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, PRRUF's ROE is -0.53%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, PRRUF and MDCLF have similar daily volatility (0.00).Check MDCLF's competition here
PRRUF vs NURPF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, NURPF has a market cap of 1.1B. Regarding current trading prices, PRRUF is priced at $0.07, while NURPF trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas NURPF's P/E ratio is 55.16. In terms of profitability, PRRUF's ROE is -0.53%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, PRRUF is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check NURPF's competition here
PRRUF vs CSBTF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, CSBTF has a market cap of 1.1B. Regarding current trading prices, PRRUF is priced at $0.07, while CSBTF trades at $27.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas CSBTF's P/E ratio is 347.38. In terms of profitability, PRRUF's ROE is -0.53%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, PRRUF is less volatile compared to CSBTF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check CSBTF's competition here
PRRUF vs IDRSF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, IDRSF has a market cap of 1.1B. Regarding current trading prices, PRRUF is priced at $0.07, while IDRSF trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas IDRSF's P/E ratio is -6.55. In terms of profitability, PRRUF's ROE is -0.53%, compared to IDRSF's ROE of +0.10%. Regarding short-term risk, PRRUF is less volatile compared to IDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check IDRSF's competition here
PRRUF vs PPTDF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, PPTDF has a market cap of 1B. Regarding current trading prices, PRRUF is priced at $0.07, while PPTDF trades at $7.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas PPTDF's P/E ratio is -44.39. In terms of profitability, PRRUF's ROE is -0.53%, compared to PPTDF's ROE of -0.03%. Regarding short-term risk, PRRUF and PPTDF have similar daily volatility (0.00).Check PPTDF's competition here
PRRUF vs BTTAY Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, PRRUF is priced at $0.07, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, PRRUF's ROE is -0.53%, compared to BTTAY's ROE of -0.05%. Regarding short-term risk, PRRUF is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check BTTAY's competition here
PRRUF vs TKBIF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, PRRUF is priced at $0.07, while TKBIF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas TKBIF's P/E ratio is -22.12. In terms of profitability, PRRUF's ROE is -0.53%, compared to TKBIF's ROE of N/A. Regarding short-term risk, PRRUF is less volatile compared to TKBIF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check TKBIF's competition here
PRRUF vs BPMUF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, BPMUF has a market cap of 853.7M. Regarding current trading prices, PRRUF is priced at $0.07, while BPMUF trades at $69.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas BPMUF's P/E ratio is 9.77. In terms of profitability, PRRUF's ROE is -0.53%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, PRRUF and BPMUF have similar daily volatility (0.00).Check BPMUF's competition here
PRRUF vs IVEVF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, IVEVF has a market cap of 799.6M. Regarding current trading prices, PRRUF is priced at $0.07, while IVEVF trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas IVEVF's P/E ratio is -2.58. In terms of profitability, PRRUF's ROE is -0.53%, compared to IVEVF's ROE of +18.92%. Regarding short-term risk, PRRUF and IVEVF have similar daily volatility (0.00).Check IVEVF's competition here
PRRUF vs VBIZF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, VBIZF has a market cap of 724.5M. Regarding current trading prices, PRRUF is priced at $0.07, while VBIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas VBIZF's P/E ratio is 34.34. In terms of profitability, PRRUF's ROE is -0.53%, compared to VBIZF's ROE of +0.06%. Regarding short-term risk, PRRUF is less volatile compared to VBIZF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check VBIZF's competition here
PRRUF vs CKDXF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, PRRUF is priced at $0.07, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, PRRUF's ROE is -0.53%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, PRRUF is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check CKDXF's competition here
PRRUF vs SOLTF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, SOLTF has a market cap of 579.2M. Regarding current trading prices, PRRUF is priced at $0.07, while SOLTF trades at $6.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas SOLTF's P/E ratio is -7.36. In terms of profitability, PRRUF's ROE is -0.53%, compared to SOLTF's ROE of -0.19%. Regarding short-term risk, PRRUF and SOLTF have similar daily volatility (0.00).Check SOLTF's competition here
PRRUF vs GNFTF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, GNFTF has a market cap of 553.4M. Regarding current trading prices, PRRUF is priced at $0.07, while GNFTF trades at $11.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas GNFTF's P/E ratio is -5.47. In terms of profitability, PRRUF's ROE is -0.53%, compared to GNFTF's ROE of -5.96%. Regarding short-term risk, PRRUF is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check GNFTF's competition here
PRRUF vs CYDY Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, CYDY has a market cap of 507.5M. Regarding current trading prices, PRRUF is priced at $0.07, while CYDY trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas CYDY's P/E ratio is -9.29. In terms of profitability, PRRUF's ROE is -0.53%, compared to CYDY's ROE of +0.37%. Regarding short-term risk, PRRUF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check CYDY's competition here
PRRUF vs INRLF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, INRLF has a market cap of 504.2M. Regarding current trading prices, PRRUF is priced at $0.07, while INRLF trades at $2.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas INRLF's P/E ratio is -3.71. In terms of profitability, PRRUF's ROE is -0.53%, compared to INRLF's ROE of -0.75%. Regarding short-term risk, PRRUF and INRLF have similar daily volatility (0.00).Check INRLF's competition here
PRRUF vs RAONF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, PRRUF is priced at $0.07, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas RAONF's P/E ratio is -43.33. In terms of profitability, PRRUF's ROE is -0.53%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, PRRUF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check RAONF's competition here
PRRUF vs GNFTY Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, PRRUF is priced at $0.07, while GNFTY trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, PRRUF's ROE is -0.53%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, PRRUF is less volatile compared to GNFTY. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check GNFTY's competition here
PRRUF vs TBGNF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, PRRUF is priced at $0.07, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, PRRUF's ROE is -0.53%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, PRRUF and TBGNF have similar daily volatility (0.00).Check TBGNF's competition here
PRRUF vs PTCHF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, PTCHF has a market cap of 428.4M. Regarding current trading prices, PRRUF is priced at $0.07, while PTCHF trades at $1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas PTCHF's P/E ratio is 10.35. In terms of profitability, PRRUF's ROE is -0.53%, compared to PTCHF's ROE of +0.13%. Regarding short-term risk, PRRUF and PTCHF have similar daily volatility (0.00).Check PTCHF's competition here
PRRUF vs NWPHF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, NWPHF has a market cap of 399.3M. Regarding current trading prices, PRRUF is priced at $0.07, while NWPHF trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas NWPHF's P/E ratio is N/A. In terms of profitability, PRRUF's ROE is -0.53%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, PRRUF is less volatile compared to NWPHF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check NWPHF's competition here
PRRUF vs AVCTF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, AVCTF has a market cap of 390.7M. Regarding current trading prices, PRRUF is priced at $0.07, while AVCTF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas AVCTF's P/E ratio is -5.95. In terms of profitability, PRRUF's ROE is -0.53%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, PRRUF is less volatile compared to AVCTF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check AVCTF's competition here
PRRUF vs CLVLY Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, CLVLY has a market cap of 351.4M. Regarding current trading prices, PRRUF is priced at $0.07, while CLVLY trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas CLVLY's P/E ratio is 15.56. In terms of profitability, PRRUF's ROE is -0.53%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, PRRUF and CLVLY have similar daily volatility (0.00).Check CLVLY's competition here
PRRUF vs SLNCF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, SLNCF has a market cap of 340.1M. Regarding current trading prices, PRRUF is priced at $0.07, while SLNCF trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas SLNCF's P/E ratio is -3.81. In terms of profitability, PRRUF's ROE is -0.53%, compared to SLNCF's ROE of -3.59%. Regarding short-term risk, PRRUF and SLNCF have similar daily volatility (0.00).Check SLNCF's competition here
PRRUF vs CLVLF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, CLVLF has a market cap of 315.2M. Regarding current trading prices, PRRUF is priced at $0.07, while CLVLF trades at $6.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas CLVLF's P/E ratio is 12.56. In terms of profitability, PRRUF's ROE is -0.53%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, PRRUF and CLVLF have similar daily volatility (0.00).Check CLVLF's competition here
PRRUF vs NGENF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, PRRUF is priced at $0.07, while NGENF trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas NGENF's P/E ratio is -15.19. In terms of profitability, PRRUF's ROE is -0.53%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, PRRUF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check NGENF's competition here
PRRUF vs SPHDF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, SPHDF has a market cap of 312.8M. Regarding current trading prices, PRRUF is priced at $0.07, while SPHDF trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas SPHDF's P/E ratio is -3.23. In terms of profitability, PRRUF's ROE is -0.53%, compared to SPHDF's ROE of -5.22%. Regarding short-term risk, PRRUF and SPHDF have similar daily volatility (0.00).Check SPHDF's competition here
PRRUF vs FGHQF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, PRRUF is priced at $0.07, while FGHQF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, PRRUF's ROE is -0.53%, compared to FGHQF's ROE of +0.02%. Regarding short-term risk, PRRUF and FGHQF have similar daily volatility (0.00).Check FGHQF's competition here
PRRUF vs NWBO Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, NWBO has a market cap of 302.4M. Regarding current trading prices, PRRUF is priced at $0.07, while NWBO trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas NWBO's P/E ratio is -3.27. In terms of profitability, PRRUF's ROE is -0.53%, compared to NWBO's ROE of +0.72%. Regarding short-term risk, PRRUF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check NWBO's competition here
PRRUF vs PBBIF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, PRRUF is priced at $0.07, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, PRRUF's ROE is -0.53%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, PRRUF and PBBIF have similar daily volatility (0.00).Check PBBIF's competition here
PRRUF vs ORPOF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, PRRUF is priced at $0.07, while ORPOF trades at $11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, PRRUF's ROE is -0.53%, compared to ORPOF's ROE of N/A. Regarding short-term risk, PRRUF and ORPOF have similar daily volatility (0.00).Check ORPOF's competition here
PRRUF vs ORYZF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, ORYZF has a market cap of 258.9M. Regarding current trading prices, PRRUF is priced at $0.07, while ORYZF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas ORYZF's P/E ratio is -83.50. In terms of profitability, PRRUF's ROE is -0.53%, compared to ORYZF's ROE of -0.03%. Regarding short-term risk, PRRUF is less volatile compared to ORYZF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check ORYZF's competition here
PRRUF vs HLOSF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, HLOSF has a market cap of 247.6M. Regarding current trading prices, PRRUF is priced at $0.07, while HLOSF trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas HLOSF's P/E ratio is -13.53. In terms of profitability, PRRUF's ROE is -0.53%, compared to HLOSF's ROE of -0.80%. Regarding short-term risk, PRRUF is less volatile compared to HLOSF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check HLOSF's competition here
PRRUF vs HNSBF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, PRRUF is priced at $0.07, while HNSBF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas HNSBF's P/E ratio is -4.08. In terms of profitability, PRRUF's ROE is -0.53%, compared to HNSBF's ROE of +1.23%. Regarding short-term risk, PRRUF is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check HNSBF's competition here
PRRUF vs SPHRY Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, SPHRY has a market cap of 226.5M. Regarding current trading prices, PRRUF is priced at $0.07, while SPHRY trades at $5.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas SPHRY's P/E ratio is -89.67. In terms of profitability, PRRUF's ROE is -0.53%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, PRRUF is less volatile compared to SPHRY. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check SPHRY's competition here
PRRUF vs CMVLF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, CMVLF has a market cap of 222.8M. Regarding current trading prices, PRRUF is priced at $0.07, while CMVLF trades at $3.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas CMVLF's P/E ratio is -4.60. In terms of profitability, PRRUF's ROE is -0.53%, compared to CMVLF's ROE of -0.70%. Regarding short-term risk, PRRUF and CMVLF have similar daily volatility (0.00).Check CMVLF's competition here
PRRUF vs CAIHF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, CAIHF has a market cap of 217.4M. Regarding current trading prices, PRRUF is priced at $0.07, while CAIHF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas CAIHF's P/E ratio is 2.80. In terms of profitability, PRRUF's ROE is -0.53%, compared to CAIHF's ROE of +0.12%. Regarding short-term risk, PRRUF is less volatile compared to CAIHF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check CAIHF's competition here
PRRUF vs BOVNF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, PRRUF is priced at $0.07, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas BOVNF's P/E ratio is -7.00. In terms of profitability, PRRUF's ROE is -0.53%, compared to BOVNF's ROE of -0.47%. Regarding short-term risk, PRRUF is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check BOVNF's competition here
PRRUF vs FPHAF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, PRRUF is priced at $0.07, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, PRRUF's ROE is -0.53%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, PRRUF and FPHAF have similar daily volatility (0.00).Check FPHAF's competition here
PRRUF vs ADOCY Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, PRRUF is priced at $0.07, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, PRRUF's ROE is -0.53%, compared to ADOCY's ROE of +1.86%. Regarding short-term risk, PRRUF and ADOCY have similar daily volatility (0.00).Check ADOCY's competition here
PRRUF vs SCNLF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, SCNLF has a market cap of 147.4M. Regarding current trading prices, PRRUF is priced at $0.07, while SCNLF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas SCNLF's P/E ratio is -14.20. In terms of profitability, PRRUF's ROE is -0.53%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, PRRUF is less volatile compared to SCNLF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check SCNLF's competition here
PRRUF vs SPHRF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, SPHRF has a market cap of 147.3M. Regarding current trading prices, PRRUF is priced at $0.07, while SPHRF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas SPHRF's P/E ratio is -35.00. In terms of profitability, PRRUF's ROE is -0.53%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, PRRUF and SPHRF have similar daily volatility (0.00).Check SPHRF's competition here
PRRUF vs TRGNF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, TRGNF has a market cap of 144.2M. Regarding current trading prices, PRRUF is priced at $0.07, while TRGNF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas TRGNF's P/E ratio is -3.03. In terms of profitability, PRRUF's ROE is -0.53%, compared to TRGNF's ROE of -0.64%. Regarding short-term risk, PRRUF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check TRGNF's competition here
PRRUF vs AMGXF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, AMGXF has a market cap of 142.5M. Regarding current trading prices, PRRUF is priced at $0.07, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, PRRUF's ROE is -0.53%, compared to AMGXF's ROE of -0.45%. Regarding short-term risk, PRRUF is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check AMGXF's competition here
PRRUF vs IPHYF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, IPHYF has a market cap of 140.7M. Regarding current trading prices, PRRUF is priced at $0.07, while IPHYF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas IPHYF's P/E ratio is -2.31. In terms of profitability, PRRUF's ROE is -0.53%, compared to IPHYF's ROE of +5.94%. Regarding short-term risk, PRRUF and IPHYF have similar daily volatility (0.00).Check IPHYF's competition here
PRRUF vs KNTPF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, KNTPF has a market cap of 140.7M. Regarding current trading prices, PRRUF is priced at $0.07, while KNTPF trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas KNTPF's P/E ratio is -5.00. In terms of profitability, PRRUF's ROE is -0.53%, compared to KNTPF's ROE of -0.63%. Regarding short-term risk, PRRUF is less volatile compared to KNTPF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check KNTPF's competition here
PRRUF vs BRIBF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, BRIBF has a market cap of 135.7M. Regarding current trading prices, PRRUF is priced at $0.07, while BRIBF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas BRIBF's P/E ratio is -3.76. In terms of profitability, PRRUF's ROE is -0.53%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, PRRUF is less volatile compared to BRIBF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check BRIBF's competition here
PRRUF vs HBPCF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, HBPCF has a market cap of 132.1M. Regarding current trading prices, PRRUF is priced at $0.07, while HBPCF trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas HBPCF's P/E ratio is -43.25. In terms of profitability, PRRUF's ROE is -0.53%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, PRRUF and HBPCF have similar daily volatility (0.00).Check HBPCF's competition here
PRRUF vs AAPGV Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, PRRUF is priced at $0.07, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas AAPGV's P/E ratio is N/A. In terms of profitability, PRRUF's ROE is -0.53%, compared to AAPGV's ROE of -1.24%. Regarding short-term risk, PRRUF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check AAPGV's competition here
PRRUF vs BXPHF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, BXPHF has a market cap of 119.4M. Regarding current trading prices, PRRUF is priced at $0.07, while BXPHF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas BXPHF's P/E ratio is -2.00. In terms of profitability, PRRUF's ROE is -0.53%, compared to BXPHF's ROE of -1.31%. Regarding short-term risk, PRRUF is less volatile compared to BXPHF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check BXPHF's competition here
PRRUF vs PSTTF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, PRRUF is priced at $0.07, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, PRRUF's ROE is -0.53%, compared to PSTTF's ROE of N/A. Regarding short-term risk, PRRUF and PSTTF have similar daily volatility (0.00).Check PSTTF's competition here
PRRUF vs JWCTF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, JWCTF has a market cap of 116.6M. Regarding current trading prices, PRRUF is priced at $0.07, while JWCTF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas JWCTF's P/E ratio is -1.40. In terms of profitability, PRRUF's ROE is -0.53%, compared to JWCTF's ROE of -0.75%. Regarding short-term risk, PRRUF and JWCTF have similar daily volatility (0.00).Check JWCTF's competition here
PRRUF vs ATGGF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, ATGGF has a market cap of 113.5M. Regarding current trading prices, PRRUF is priced at $0.07, while ATGGF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas ATGGF's P/E ratio is N/A. In terms of profitability, PRRUF's ROE is -0.53%, compared to ATGGF's ROE of -1.34%. Regarding short-term risk, PRRUF is less volatile compared to ATGGF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check ATGGF's competition here
PRRUF vs NDTP Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, NDTP has a market cap of 112M. Regarding current trading prices, PRRUF is priced at $0.07, while NDTP trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas NDTP's P/E ratio is -2.41. In terms of profitability, PRRUF's ROE is -0.53%, compared to NDTP's ROE of -0.33%. Regarding short-term risk, PRRUF is less volatile compared to NDTP. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check NDTP's competition here
PRRUF vs EPRXF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, PRRUF is priced at $0.07, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, PRRUF's ROE is -0.53%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, PRRUF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check EPRXF's competition here
PRRUF vs ADOIF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, PRRUF is priced at $0.07, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, PRRUF's ROE is -0.53%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, PRRUF and ADOIF have similar daily volatility (0.00).Check ADOIF's competition here
PRRUF vs MSCLF Comparison April 2026
PRRUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PRRUF stands at 95.8M. In comparison, MSCLF has a market cap of 96.6M. Regarding current trading prices, PRRUF is priced at $0.07, while MSCLF trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PRRUF currently has a P/E ratio of -0.93, whereas MSCLF's P/E ratio is 2.43. In terms of profitability, PRRUF's ROE is -0.53%, compared to MSCLF's ROE of -0.70%. Regarding short-term risk, PRRUF is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for PRRUF.Check MSCLF's competition here